Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1992 Nov;216(5):583–590. doi: 10.1097/00000658-199211000-00010

Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy.

T Lerut 1, P De Leyn 1, W Coosemans 1, D Van Raemdonck 1, I Scheys 1, E LeSaffre 1
PMCID: PMC1242677  PMID: 1444650

Abstract

From 1975 through 1988, 257 patients with carcinoma of the thoracic esophagus have been treated in our department. Operability was 90% (232/257); overall resectability, 77% (198/257), and for the operated group, 85% (198/232). Hospital mortality rate was 9.6% but decreased to 3% over the period 1986 to 1988. There were 65% squamous cell epitheliomas and 35% adenocarcinomas. Tumor, nodes, and metastases (pTNM) staging was as follows: stage I, 11.6%; stage II, 23.2%; stage III, 37.9%; stage IV, 27.3%. Overall survival rate was 62.5% at 1 year, 42.4% at 2 years, and 30% at 5 years. According to the pTNM staging, 5-year survival was 90% for stage I, 56% for stage II, 15.3% for stage III, and 0 for stage IV. There were no statistically significant differences according to tumor localization, pathologic type, sex, or age. Introducing extensive resection and extended lymphadenectomy seems to improve significantly survival in patients in whom an operation with curative intention was performed, the 1 year survival rate being 90.8% versus 72%; 2-year survival, 81% versus 46%; and 5-year survival, 48.5% versus 41% for radical and nonradical resections, respectively. Based on multivariate Cox regression analysis, only TNM stage and presence or absence of lymph nodes are important factors in predicting survival: stage 1 tumors have lower risk, and involvement of lymph nodes creates higher risk. Using this analysis, there was only for the patients with involved lymph nodes (N1) a significantly better prognosis when a radical lymph node dissection was performed (p = 0.0055). Barrett adenocarcinomas have no worse prognosis than other esophageal carcinomas, with a 5-year survival rate of 91.5% if lymph nodes are negative, and a 54% overall 5-year survival rate. Functional results after restoration of continuity with gastric tubulation were judged excellent to very good in 86.5% at 1 year, but infra-aortic anastomoses have a much higher incidence of peptic esophagitis: 53% versus 8% for cervical anastomoses. From this study it can be concluded that in experienced hands surgery today offers the best chances for optimal staging, potential cure, and prolonged high-quality palliation.

Full text

PDF
583

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiyama H., Tsurumaru M., Kawamura T., Ono Y. Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement. Ann Surg. 1981 Oct;194(4):438–446. doi: 10.1097/00000658-198110000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Altorki N. K., Skinner D. B. En bloc esophagectomy: the first 100 patients. Hepatogastroenterology. 1990 Aug;37(4):360–363. [PubMed] [Google Scholar]
  3. De Leyn P., Coosemans W., Lerut T. Early and late functional results in patients with intrathoracic gastric replacement after oesophagectomy for carcinoma. Eur J Cardiothorac Surg. 1992;6(2):79–85. doi: 10.1016/1010-7940(92)90079-d. [DOI] [PubMed] [Google Scholar]
  4. Drucker M. H., Mansour K. A., Hatcher C. R., Jr, Symbas P. N. Esophageal carcinoma: an aggressive approach. Ann Thorac Surg. 1979 Aug;28(2):133–138. doi: 10.1016/s0003-4975(10)63770-8. [DOI] [PubMed] [Google Scholar]
  5. Earlam R., Cunha-Melo J. R. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg. 1980 Jun;67(6):381–390. doi: 10.1002/bjs.1800670602. [DOI] [PubMed] [Google Scholar]
  6. Earlam R., Cunha-Melo J. R. Oesophogeal squamous cell carcinoms: II. A critical view of radiotherapy. Br J Surg. 1980 Jul;67(7):457–461. doi: 10.1002/bjs.1800670702. [DOI] [PubMed] [Google Scholar]
  7. Fleischer D. Endoscopic laser therapy for esophageal cancer: present status with emphasis on past and future. Lasers Surg Med. 1989;9(1):6–16. doi: 10.1002/lsm.1900090104. [DOI] [PubMed] [Google Scholar]
  8. Gignoux M., Roussel A., Paillot B., Gillet M., Schlag P., Favre J. P., Dalesio O., Buyse M., Duez N. The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg. 1987 Aug;11(4):426–432. doi: 10.1007/BF01655805. [DOI] [PubMed] [Google Scholar]
  9. Hölscher A. H., Voit H., Buttermann G., Siewert J. R. Function of the intrathoracic stomach as esophageal replacement. World J Surg. 1988 Dec;12(6):835–844. doi: 10.1007/BF01655491. [DOI] [PubMed] [Google Scholar]
  10. Leichman L., Herskovic A., Leichman C. G., Lattin P. B., Steiger Z., Tapazoglou E., Rosenberg J. C., Arbulu A., Asfaw I., Kinzie J. Nonoperative therapy for squamous-cell cancer of the esophagus. J Clin Oncol. 1987 Mar;5(3):365–370. doi: 10.1200/JCO.1987.5.3.365. [DOI] [PubMed] [Google Scholar]
  11. Matsufuji H., Kuwano H., Kai H., Matsuda H., Sugimachi K. Preoperative hyperthermia combined with radiotherapy and chemotherapy for patients with incompletely resected carcinoma of the esophagus. Cancer. 1988 Sep 1;62(5):889–894. doi: 10.1002/1097-0142(19880901)62:5<889::aid-cncr2820620507>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  12. Matthews H. R., Powell D. J., McConkey C. C. Effect of surgical experience on the results of resection for oesophageal carcinoma. Br J Surg. 1986 Aug;73(8):621–623. doi: 10.1002/bjs.1800730811. [DOI] [PubMed] [Google Scholar]
  13. Müller J. M., Erasmi H., Stelzner M., Zieren U., Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg. 1990 Aug;77(8):845–857. doi: 10.1002/bjs.1800770804. [DOI] [PubMed] [Google Scholar]
  14. Orringer M. B. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg. 1984 Sep;200(3):282–288. doi: 10.1097/00000658-198409000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pearson J. G. The radiotherapy of carcinoma of the oesophagus and post cricoid region in south east Scotland. Clin Radiol. 1966 Jul;17(3):242–257. doi: 10.1016/s0009-9260(66)80030-2. [DOI] [PubMed] [Google Scholar]
  16. Rutgeerts P., Vantrappen G., Broeckaert L., Muls M., Geboes K., Coremans G., Janssens J. Palliative Nd:YAG laser therapy for cancer of the esophagus and gastroesophageal junction: impact on the quality of remaining life. Gastrointest Endosc. 1988 Mar-Apr;34(2):87–90. doi: 10.1016/s0016-5107(88)71269-9. [DOI] [PubMed] [Google Scholar]
  17. Sugimachi K., Matsuda H., Ohno S., Fukuda A., Matsuoka H., Mori M., Kuwano H. Long-term effects of hyperthermia combined with chemotherapy and irradiation for the treatment of patients with carcinoma of the esophagus. Surg Gynecol Obstet. 1988 Oct;167(4):319–323. [PubMed] [Google Scholar]
  18. Tio T. L., Coene P. P., den Hartog Jager F. C., Tytgat G. N. Preoperative TNM classification of esophageal carcinoma by endosonography. Hepatogastroenterology. 1990 Aug;37(4):376–381. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES